 | • レポートコード：MRC23Q36573 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の抗てんかん薬中間体市場について調査・分析し、世界の抗てんかん薬中間体市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（3,4,5-トリメトキシベンズアルデヒド、フェニル酢酸、その他）、用途別セグメント分析（経口薬、注射薬）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Aba Chemicals、Senxuan Pharmaceutical、Nandkrishna Chemicals、Shouguang Fukang Pharmaceutical、Holly Pharmaceuticalなどが含まれています。世界の抗てんかん薬中間体市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、抗てんかん薬中間体市場規模を推定する際に考慮しました。本レポートは、抗てんかん薬中間体の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、抗てんかん薬中間体に関するビジネス上の意思決定に役立てることを目的としています。 ・抗てんかん薬中間体市場の概要 - 製品の定義 - 抗てんかん薬中間体のタイプ別セグメント - 世界の抗てんかん薬中間体市場規模：タイプ別分析（3,4,5-トリメトキシベンズアルデヒド、フェニル酢酸、その他） - 抗てんかん薬中間体の用途別セグメント - 世界の抗てんかん薬中間体市場規模：用途別分析（経口薬、注射薬） - 世界の抗てんかん薬中間体市場規模予測（2018年-2029年） - 抗てんかん薬中間体の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 抗てんかん薬中間体市場の競争状況およびトレンド ・抗てんかん薬中間体の地域別市場規模 - 北米の抗てんかん薬中間体市場規模（2018年-2029年） - アメリカの抗てんかん薬中間体市場規模（2018年-2029年） - ヨーロッパの抗てんかん薬中間体市場規模（2018年-2029年） - アジア太平洋の抗てんかん薬中間体市場規模（2018年-2029年） - 中国の抗てんかん薬中間体市場規模（2018年-2029年） - 日本の抗てんかん薬中間体市場規模（2018年-2029年） - 韓国の抗てんかん薬中間体市場規模（2018年-2029年） - インドの抗てんかん薬中間体市場規模（2018年-2029年） - オーストラリアの抗てんかん薬中間体市場規模（2018年-2029年） - 中南米の抗てんかん薬中間体市場規模（2018年-2029年） - 中東・アフリカの抗てんかん薬中間体市場規模（2018年-2029年） ・タイプ別セグメント：3,4,5-トリメトキシベンズアルデヒド、フェニル酢酸、その他 - 世界の抗てんかん薬中間体のタイプ別販売量（2018年-2023年） - 世界の抗てんかん薬中間体のタイプ別売上（2018年-2023年） - 世界の抗てんかん薬中間体のタイプ別価格 ・用途別セグメント：経口薬、注射薬 - 世界の抗てんかん薬中間体の用途別販売量（2018年-2023年） - 世界の抗てんかん薬中間体の用途別売上（2018年-2023年） - 世界の抗てんかん薬中間体の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Aba Chemicals、Senxuan Pharmaceutical、Nandkrishna Chemicals、Shouguang Fukang Pharmaceutical、Holly Pharmaceutical ・産業チェーンと販売チャネルの分析 - 抗てんかん薬中間体産業チェーン分析 - 抗てんかん薬中間体の主要原材料 - 抗てんかん薬中間体の販売チャネル - 抗てんかん薬中間体のディストリビューター - 抗てんかん薬中間体の主要顧客 ・抗てんかん薬中間体市場ダイナミクス - 抗てんかん薬中間体の業界動向 - 抗てんかん薬中間体市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Anti-Epileptic Pharmaceutical Intermediates market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Anti-Epileptic Pharmaceutical Intermediates is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Anti-Epileptic Pharmaceutical Intermediates is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Anti-Epileptic Pharmaceutical Intermediates include Aba Chemicals, Senxuan Pharmaceutical, Nandkrishna Chemicals, Shouguang Fukang Pharmaceutical and Holly Pharmaceutical, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-Epileptic Pharmaceutical Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Epileptic Pharmaceutical Intermediates.
The Anti-Epileptic Pharmaceutical Intermediates market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anti-Epileptic Pharmaceutical Intermediates market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Epileptic Pharmaceutical Intermediates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Aba Chemicals
Senxuan Pharmaceutical
Nandkrishna Chemicals
Shouguang Fukang Pharmaceutical
Holly Pharmaceutical
Segment by Type
3,4,5-Trimethoxybenzaldehyde
Phenylacetic Acid
Others
Segment by Application
Oral Drugs
Injectable Drugs
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Epileptic Pharmaceutical Intermediates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Epileptic Pharmaceutical Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Anti-Epileptic Pharmaceutical Intermediates Market Overview
1.1 Product Overview and Scope of Anti-Epileptic Pharmaceutical Intermediates
1.2 Anti-Epileptic Pharmaceutical Intermediates Segment by Type
1.2.1 Global Anti-Epileptic Pharmaceutical Intermediates Market Value Comparison by Type (2023-2029)
1.2.2 3,4,5-Trimethoxybenzaldehyde
1.2.3 Phenylacetic Acid
1.2.4 Others
1.3 Anti-Epileptic Pharmaceutical Intermediates Segment by Application
1.3.1 Global Anti-Epileptic Pharmaceutical Intermediates Market Value by Application: (2023-2029)
1.3.2 Oral Drugs
1.3.3 Injectable Drugs
1.4 Global Anti-Epileptic Pharmaceutical Intermediates Market Size Estimates and Forecasts
1.4.1 Global Anti-Epileptic Pharmaceutical Intermediates Revenue 2018-2029
1.4.2 Global Anti-Epileptic Pharmaceutical Intermediates Sales 2018-2029
1.4.3 Global Anti-Epileptic Pharmaceutical Intermediates Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Anti-Epileptic Pharmaceutical Intermediates Market Competition by Manufacturers
2.1 Global Anti-Epileptic Pharmaceutical Intermediates Sales Market Share by Manufacturers (2018-2023)
2.2 Global Anti-Epileptic Pharmaceutical Intermediates Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Anti-Epileptic Pharmaceutical Intermediates Average Price by Manufacturers (2018-2023)
2.4 Global Anti-Epileptic Pharmaceutical Intermediates Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Anti-Epileptic Pharmaceutical Intermediates, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Epileptic Pharmaceutical Intermediates, Product Type & Application
2.7 Anti-Epileptic Pharmaceutical Intermediates Market Competitive Situation and Trends
2.7.1 Anti-Epileptic Pharmaceutical Intermediates Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Epileptic Pharmaceutical Intermediates Players Market Share by Revenue
2.7.3 Global Anti-Epileptic Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Epileptic Pharmaceutical Intermediates Retrospective Market Scenario by Region
3.1 Global Anti-Epileptic Pharmaceutical Intermediates Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Anti-Epileptic Pharmaceutical Intermediates Global Anti-Epileptic Pharmaceutical Intermediates Sales by Region: 2018-2029
3.2.1 Global Anti-Epileptic Pharmaceutical Intermediates Sales by Region: 2018-2023
3.2.2 Global Anti-Epileptic Pharmaceutical Intermediates Sales by Region: 2024-2029
3.3 Global Anti-Epileptic Pharmaceutical Intermediates Global Anti-Epileptic Pharmaceutical Intermediates Revenue by Region: 2018-2029
3.3.1 Global Anti-Epileptic Pharmaceutical Intermediates Revenue by Region: 2018-2023
3.3.2 Global Anti-Epileptic Pharmaceutical Intermediates Revenue by Region: 2024-2029
3.4 North America Anti-Epileptic Pharmaceutical Intermediates Market Facts & Figures by Country
3.4.1 North America Anti-Epileptic Pharmaceutical Intermediates Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Anti-Epileptic Pharmaceutical Intermediates Sales by Country (2018-2029)
3.4.3 North America Anti-Epileptic Pharmaceutical Intermediates Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-Epileptic Pharmaceutical Intermediates Market Facts & Figures by Country
3.5.1 Europe Anti-Epileptic Pharmaceutical Intermediates Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Anti-Epileptic Pharmaceutical Intermediates Sales by Country (2018-2029)
3.5.3 Europe Anti-Epileptic Pharmaceutical Intermediates Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Epileptic Pharmaceutical Intermediates Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Epileptic Pharmaceutical Intermediates Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Anti-Epileptic Pharmaceutical Intermediates Sales by Country (2018-2029)
3.6.3 Asia Pacific Anti-Epileptic Pharmaceutical Intermediates Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anti-Epileptic Pharmaceutical Intermediates Market Facts & Figures by Country
3.7.1 Latin America Anti-Epileptic Pharmaceutical Intermediates Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Anti-Epileptic Pharmaceutical Intermediates Sales by Country (2018-2029)
3.7.3 Latin America Anti-Epileptic Pharmaceutical Intermediates Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-Epileptic Pharmaceutical Intermediates Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Epileptic Pharmaceutical Intermediates Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Anti-Epileptic Pharmaceutical Intermediates Sales by Country (2018-2029)
3.8.3 Middle East and Africa Anti-Epileptic Pharmaceutical Intermediates Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Epileptic Pharmaceutical Intermediates Sales by Type (2018-2029)
4.1.1 Global Anti-Epileptic Pharmaceutical Intermediates Sales by Type (2018-2023)
4.1.2 Global Anti-Epileptic Pharmaceutical Intermediates Sales by Type (2024-2029)
4.1.3 Global Anti-Epileptic Pharmaceutical Intermediates Sales Market Share by Type (2018-2029)
4.2 Global Anti-Epileptic Pharmaceutical Intermediates Revenue by Type (2018-2029)
4.2.1 Global Anti-Epileptic Pharmaceutical Intermediates Revenue by Type (2018-2023)
4.2.2 Global Anti-Epileptic Pharmaceutical Intermediates Revenue by Type (2024-2029)
4.2.3 Global Anti-Epileptic Pharmaceutical Intermediates Revenue Market Share by Type (2018-2029)
4.3 Global Anti-Epileptic Pharmaceutical Intermediates Price by Type (2018-2029)
5 Segment by Application
5.1 Global Anti-Epileptic Pharmaceutical Intermediates Sales by Application (2018-2029)
5.1.1 Global Anti-Epileptic Pharmaceutical Intermediates Sales by Application (2018-2023)
5.1.2 Global Anti-Epileptic Pharmaceutical Intermediates Sales by Application (2024-2029)
5.1.3 Global Anti-Epileptic Pharmaceutical Intermediates Sales Market Share by Application (2018-2029)
5.2 Global Anti-Epileptic Pharmaceutical Intermediates Revenue by Application (2018-2029)
5.2.1 Global Anti-Epileptic Pharmaceutical Intermediates Revenue by Application (2018-2023)
5.2.2 Global Anti-Epileptic Pharmaceutical Intermediates Revenue by Application (2024-2029)
5.2.3 Global Anti-Epileptic Pharmaceutical Intermediates Revenue Market Share by Application (2018-2029)
5.3 Global Anti-Epileptic Pharmaceutical Intermediates Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Aba Chemicals
6.1.1 Aba Chemicals Corporation Information
6.1.2 Aba Chemicals Description and Business Overview
6.1.3 Aba Chemicals Anti-Epileptic Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Aba Chemicals Anti-Epileptic Pharmaceutical Intermediates Product Portfolio
6.1.5 Aba Chemicals Recent Developments/Updates
6.2 Senxuan Pharmaceutical
6.2.1 Senxuan Pharmaceutical Corporation Information
6.2.2 Senxuan Pharmaceutical Description and Business Overview
6.2.3 Senxuan Pharmaceutical Anti-Epileptic Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Senxuan Pharmaceutical Anti-Epileptic Pharmaceutical Intermediates Product Portfolio
6.2.5 Senxuan Pharmaceutical Recent Developments/Updates
6.3 Nandkrishna Chemicals
6.3.1 Nandkrishna Chemicals Corporation Information
6.3.2 Nandkrishna Chemicals Description and Business Overview
6.3.3 Nandkrishna Chemicals Anti-Epileptic Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Nandkrishna Chemicals Anti-Epileptic Pharmaceutical Intermediates Product Portfolio
6.3.5 Nandkrishna Chemicals Recent Developments/Updates
6.4 Shouguang Fukang Pharmaceutical
6.4.1 Shouguang Fukang Pharmaceutical Corporation Information
6.4.2 Shouguang Fukang Pharmaceutical Description and Business Overview
6.4.3 Shouguang Fukang Pharmaceutical Anti-Epileptic Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shouguang Fukang Pharmaceutical Anti-Epileptic Pharmaceutical Intermediates Product Portfolio
6.4.5 Shouguang Fukang Pharmaceutical Recent Developments/Updates
6.5 Holly Pharmaceutical
6.5.1 Holly Pharmaceutical Corporation Information
6.5.2 Holly Pharmaceutical Description and Business Overview
6.5.3 Holly Pharmaceutical Anti-Epileptic Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Holly Pharmaceutical Anti-Epileptic Pharmaceutical Intermediates Product Portfolio
6.5.5 Holly Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Epileptic Pharmaceutical Intermediates Industry Chain Analysis
7.2 Anti-Epileptic Pharmaceutical Intermediates Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Epileptic Pharmaceutical Intermediates Production Mode & Process
7.4 Anti-Epileptic Pharmaceutical Intermediates Sales and Marketing
7.4.1 Anti-Epileptic Pharmaceutical Intermediates Sales Channels
7.4.2 Anti-Epileptic Pharmaceutical Intermediates Distributors
7.5 Anti-Epileptic Pharmaceutical Intermediates Customers
8 Anti-Epileptic Pharmaceutical Intermediates Market Dynamics
8.1 Anti-Epileptic Pharmaceutical Intermediates Industry Trends
8.2 Anti-Epileptic Pharmaceutical Intermediates Market Drivers
8.3 Anti-Epileptic Pharmaceutical Intermediates Market Challenges
8.4 Anti-Epileptic Pharmaceutical Intermediates Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer